Related Experiment Video
Updated: Jun 1, 2026
09:43
The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents
Published on: August 10, 2014
The functional 5-HT1A receptor polymorphism affects response inhibition processes in a context-dependent manner
Christian Beste1, Katharina Domschke, Britta Radenz
1Institute for Cognitive Neuroscience, Department of Biopsychology, Ruhr-Universität Bochum, Universitätsstrasse 150, D-44780 Bochum, Germany. christian.beste@rub.de
Neuropsychologia
|June 8, 2011
Summary
The serotonin 1A receptor gene (5-HT1A C(-1019)G) influences cognitive control. Certain genetic variations enhance performance when context is misleading but impair it when context is helpful.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Genetics
Background:
- Cognitive control relies on context, which can aid or hinder performance.
- Neurobiological underpinnings of context-dependent cognitive control are unclear.
- The serotonin 1A receptor polymorphism (5-HT1A C(-1019)G) is implicated in brain function.
Purpose of the Study:
- Investigate the role of the 5-HT1A C(-1019)G polymorphism in context-dependent cognitive control.
- Examine event-related potentials (ERPs) to understand neurobiological mechanisms.
- Assess the influence of anxiety sensitivity on these effects.
Main Methods:
- Utilized the AX-Continuous Performance Task (AX-CPT) in 90 healthy subjects.
- Measured event-related potentials (ERPs), specifically the (Nogo)-P3 component.
- Genotyped the 5-HT1A C(-1019)G polymorphism and assessed anxiety sensitivity.
Main Results:
- Carriers of the -1019G allele showed impaired cognitive control when context was beneficial.
- These individuals demonstrated enhanced performance when context was misleading.
- Modulations in the (Nogo)-P3 ERP component paralleled behavioral findings.
- Anxiety sensitivity further modulated the effects of the 5-HT1A polymorphism.
Conclusions:
- The 5-HT1A C(-1019)G polymorphism impacts cognitive control, offering advantages when context is detrimental.
- Findings suggest the dorsal raphe nucleus (DRN) may mediate context-dependent cognitive control.
- This polymorphism, despite anxiety disorder risk, confers benefits in specific cognitive control scenarios.
More Related Videos
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...